Faculty Disclosure Summary
 
 
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Commercial Support, it is the policy of the George Washington University School of Medicine and Health Sciences to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. 
 
In accordance with this policy, all individuals involved in the development and presentation of CME activity content must disclose any relevant financial relationships they have with a commercial interest(s). Any identified conflicts of interest are resolved prior to the individual’s participation in the educational activity.
 

Disclosure of No Commercial Relationships

Faculty & Planners

 
The following faculty and planners, upon submission of a disclosure form, made no disclosures of commercial relationships:
 
  • Robert Siegel, MD (Course Director)
  • Edward Chu, MD
  • Susan Dentzer
  • Lynt Johnson, MD
  • Henry Masur, MD
  • Keith Mortman, MD

Staff

The George Washington University School of Medicine and Health Sciences CEHP Office staff members have disclosed no relevant financial relationships.
 

Disclosure of Commercial Relationships

 
The following faculty, upon submission of a disclosure form, disclosed financial relationships with commercial interests:
 
Faculty Member
Disclosure
Carey Anders, MD

 

  • Consultant: Genetech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis
  • Research Funding: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1- Therapeutics
Jeanny Aragon-Ching, MD, FACP
  • Advisory Board: Bayer, Merck
  • Consultant: Sanofi/Genzyme
  • Speaker’s Bureau: Bristol Myers Squibb, Astellas/Seattle Genetics
Benjamin Levy, MD
  • Consultant: Merck, Celgene, Takeda, Pfizer, Genentech, Eli Lilly, Guardant, and Astra Zeneca
John Marshall, MD
  • Advisory Board: Indivumed
  • Consultant: Bayer, Merck, Taiho
  • Speaker’s Bureau: Bayer, Caris, Merck,Taiho